Prudêncio Miguel, Rodrigues Cristina D, Hannus Michael, Martin Cécilie, Real Eliana, Gonçalves Lígia A, Carret Céline, Dorkin Robert, Röhl Ingo, Jahn-Hoffmann Kerstin, Luty Adrian J F, Sauerwein Robert, Echeverri Christophe J, Mota Maria M
Unidade de Malária, Instituto de Medicina Molecular, Universidade de Lisboa, Lisboa, Portugal.
PLoS Pathog. 2008 Nov;4(11):e1000201. doi: 10.1371/journal.ppat.1000201. Epub 2008 Nov 7.
Plasmodium sporozoites, the causative agent of malaria, are injected into their vertebrate host through the bite of an infected Anopheles mosquito, homing to the liver where they invade hepatocytes to proliferate and develop into merozoites that, upon reaching the bloodstream, give rise to the clinical phase of infection. To investigate how host cell signal transduction pathways affect hepatocyte infection, we used RNAi to systematically test the entire kinome and associated genes in human Huh7 hepatoma cells for their potential roles during infection by P. berghei sporozoites. The three-phase screen covered 727 genes, which were tested with a total of 2,307 individual siRNAs using an automated microscopy assay to quantify infection rates and qRT-PCR to assess silencing levels. Five protein kinases thereby emerged as top hits, all of which caused significant reductions in infection when silenced by RNAi. Follow-up validation experiments on one of these hits, PKCsigma (PKCzeta), confirmed the physiological relevance of our findings by reproducing the inhibitory effect on P. berghei infection in adult mice treated systemically with liposome-formulated PKCsigma-targeting siRNAs. Additional cell-based analyses using a pseudo-substrate inhibitor of PKCsigma added further RNAi-independent support, indicating a role for host PKCsigma on the invasion of hepatocytes by sporozoites. This study represents the first comprehensive, functional genomics-driven identification of novel host factors involved in Plasmodium sporozoite infection.
疟原虫子孢子是疟疾的病原体,通过受感染按蚊的叮咬注入脊椎动物宿主,归巢至肝脏,在那里它们侵入肝细胞进行增殖并发育成裂殖子,裂殖子进入血液后引发感染的临床阶段。为了研究宿主细胞信号转导通路如何影响肝细胞感染,我们利用RNA干扰技术系统地检测了人Huh7肝癌细胞中的整个激酶组及相关基因在伯氏疟原虫子孢子感染过程中的潜在作用。三阶段筛选涵盖了727个基因,使用自动显微镜检测法对感染率进行定量,并通过qRT-PCR评估沉默水平,共使用2307个单独的小干扰RNA对这些基因进行了检测。由此发现了5种蛋白激酶表现突出,通过RNA干扰使其沉默时,所有这些激酶均导致感染率显著降低。对其中一个突出的激酶PKCsigma(PKCzeta)进行的后续验证实验,通过对全身注射脂质体包裹的靶向PKCsigma的小干扰RNA的成年小鼠再现对伯氏疟原虫感染的抑制作用,证实了我们研究结果的生理相关性。使用PKCsigma的假底物抑制剂进行的其他基于细胞的分析进一步提供了与RNA干扰无关的支持,表明宿主PKCsigma在子孢子侵入肝细胞过程中发挥作用。这项研究代表了首次通过全面的、功能基因组学驱动的方法鉴定出参与疟原虫子孢子感染的新型宿主因子。